New hope for kids with blood cancer in malawi: tailored treatment study launches
NCT ID NCT06928909
First seen Apr 21, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study is testing a treatment guideline designed for children with acute myeloid leukemia (AML) in Malawi, where resources are limited. It will enroll 30 children under 18 to see if the adapted plan is both feasible and effective at achieving remission. The goal is to improve survival rates by balancing strong treatment with manageable side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kamuzu Central Hospital
RECRUITINGLilongwe, Lilongwe, Malawi
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.